Table: begin end state 1 26 cytoplasmic 27 47 transmembrane 48 52 non-cytoplasmic 53 70 transmembrane 71 105 cytoplasmic 106 128 transmembrane 129 134 non-cytoplasmic 135 153 transmembrane 154 161 cytoplasmic 162 183 transmembrane 184 204 non-cytoplasmic 205 227 transmembrane 228 247 cytoplasmic 248 270 transmembrane 271 289 non-cytoplasmic 290 308 transmembrane 309 338 cytoplasmic 339 361 transmembrane 362 366 non-cytoplasmic 367 387 transmembrane 388 406 cytoplasmic 407 427 transmembrane 428 432 non-cytoplasmic 433 452 transmembrane 453 458 cytoplasmic
Input: >BWI76_RS07360 MKDASTSSETIEESGPTLHRGLQNRHIQLIALGGAIGTGLFLGIGPAIQMAGPAVLLGYA VAGIVAFLIMRQLGEMVVEEPVSGSFAHFAYKYWGPFAGFLSGWNYWVMFVLVGMAELTA AGIYMQYWLPDVPTWIWAAAFFLIINAVNLVNVRLYGEAEFWFALIKVLAIIGMIGFGLW MLFGGHGGSKAGIDNLWKHGGFFATGWHGLIMSLAVIMFSFGGLELIGITAAEAQNPEKS IPKAVNQVVYRILLFYIGSLVVLLALYPWVEIQSDSSPFVMIFHNLDSNVVASALNFVIL VASLSVYNSGVYSNSRMLFGLSVQGNAPKFLARVSKRGVPVNSLLLSGIITSLVVVLNYL LPQKALGLLMALVVATLLLNWIMICLAHLKFRAAQRRKGREPKFKALLSPASNYICIAFL ALILVLMCTIDGMRLSAILLPVWILFLFAAFKTLRRTA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server